Ignite Creation Date:
2024-05-06 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 2:29 PM
Study NCT ID:
NCT05322720
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-04-12
First Post:
2022-03-10
Brief Title:
HR Positive HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy
Sponsor:
Taizhou EOC Pharma Co Ltd
Organization:
Taizhou EOC Pharma Co Ltd
Organization Data
Organization:
Taizhou EOC Pharma Co Ltd
Class:
INDUSTRY
Study ID:
EOC202A2102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Taizhou EOC Pharma Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None